Lilly Korea launches Byetta injections

Published: 2008-11-20 06:55:00
Updated: 2008-11-20 06:55:00
Lilly Korea has launched Byetta (exenatide), the first in a new class of medications specifically created to treat type 2 diabetes.

Byetta (5 mcg exenatide or 10 mcg exenatide) is indicated as an add-on therapy for use twice a day in adults with type 2 diabetes who are unsuccessful at controll...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.